Ulcerative colitis: Patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1692-1701

  Höie, Ole ^a,j   Wolters, Frank ^b   Riis, Lene ^c   Aamodt, Geir ^d   Solberg, Camilla ^e   Bernklev, Tomm ^d   Odes, Selwyn ^f   Mouzas, Iannis A ^g   Beltrami, Marina ^h   Langholz, Ebbe ^c   Stockbrügger, Reinhold ^b   Vatn, Morten ^d   Moum, Bjorn ⁱ  

^a Sorlandet Hospital   (Norway)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF OSLO   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ AKER UNIVERSITY HOSPITAL   (Norway)

^j NONE   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; MERCAPTOPURINE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSAL ATTRIBUTION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLITIS, ULCERATIVE; EDUCATIONAL STATUS; EUROPE; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SEX FACTORS; SMOKING;

EID: 34547646333     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01265.x     Document Type: Article

References (34)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 17.
2. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963 41 : 299 315.
3. Stockbrugger RW, Russel MG, van Blankenstein M, et al. EC-IBD: A European effort in inflammatory bowel disease. Eur J Intern Med 2000 11 : 187 90.
4. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989 170 : 2 6.
5. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996 39 : 690 7.
6. Wolters FL, van Zeijl G, Sijbrandij J, et al. Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: Description of methods used and analysis of factors influencing response rates. World J Gastroenterol 2005 11 : 7152 8.
7. Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol 1997 11 : 53 64.
8. Stewenius J, Adnerhill I, Ekelund GR, et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum 1996 39 : 1019 25.
9. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994 107 : 3 11.
10. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985 26 (2 158 63.
11. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001 120 : 13 20.
12. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997 32 : 1005 12.
13. Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: A community study. Gastroenterology 1983 85 : 1 11.
14. Hiwatashi N, Yamazaki H, Kimura M, et al. Clinical course and long-term prognosis of Japanese patients with ulcerative colitis. Gastroenterol Jpn 1991 26 : 312 8.
15. Lindberg E, Tysk C, Andersson K, et al. Smoking and inflammatory bowel disease. A case control study. Gut 1988 29 : 352 7.
16. Motley RJ, Rhodes J, Ford GA, et al. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 1987 37 : 125 7.
17. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in a European cohort followed for ten years. Gastroenterology 2007 132 : 507 15.
18. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995 37 : 668 73.
19. Wolters FL, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006 55 : 1124 30.
20. Bernklev T, Jahnsen J, Aadland E, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004 39 : 365 73.
21. McColl M, Shortt S. Another way to look at high service utilization: The contribution of disability. J Health Serv Res Policy 2006 11 : 74 80.
22. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990 31 : 1037 40.
23. Bernstein CN, Kraut A, Blanchard JF, et al. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 2001 96 : 2117 25.
24. Marri SR, Buchman AL. The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis 2005 11 : 171 7.
25. Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg Suppl 1998 582 : 90 8.
26. Sack DM, Peppercorn MA. Drug therapy of inflammatory bowel disease. Pharmacotherapy 1983 3 : 158 76.
27. Riley SA, Mani V, Goodman MJ, et al. Why do patients with ulcerative colitis relapse Gut 1990 31 : 179 83.
28. Beattie RM, Nicholls SW, Domizio P, et al. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1996 22 : 373 9.
29. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 353 : 2462 76.
30. Chung PY, Cohen RD. Evolving medical therapies for ulcerative colitis. Curr Gastroenterol Rep 2001 3 : 464 70.
31. Moum B. Medical treatment: Does it influence the natural course of inflammatory bowel disease Eur J Intern Med 2000 11 : 197 203.
32. Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997 9 : 353 9.
33. Hoie O, Schouten L, Wolters FL, et al. Ulcerative colitis: No rise in mortality in a European-wide population-based cohort 10 years after diagnosis. Gut 2007 56 : 497 503.
34. Bresci G, Parisi G, Gambardella L, et al. Evaluation of clinical patterns in ulcerative colitis: A long-term follow-up. Int J Clin Pharmacol Res 1997 17 : 17 22.